๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene

โœ Scribed by P. Vestergaard; F. Schwartz; L. Rejnmark; L. Mosekilde


Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
184 KB
Volume
22
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Subtrochanteric/femoral shaft Versus hip
โœ Milka Maravic; Agnรจs Ostertag; Martine Cohen-Solal ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› American Society for Bone and Mineral Research ๐ŸŒ English โš– 108 KB

## Abstract Subtrochanteric and femoral shaft (ST/FS) fractures are now considered to be fragility fractures in osteoporotic patients. Although rare, there is growing evidence of the burden that they constitute. Little is known about the change over time in incidence of ST/FS fractures. We assessed

Oral bisphosphonates and risk of subtroc
โœ Seo Young Kim; Sebastian Schneeweiss; Jeffrey N Katz; Raisa Levin; Daniel H Solo ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› American Society for Bone and Mineral Research ๐ŸŒ English โš– 214 KB

Bisphosphonates are the primary therapy for postmenopausal and glucocorticoid-induced osteoporosis. Case series suggest a potential link between prolonged use of bisphosphonates and low-energy fracture of subtrochanteric or diaphyseal femur as a consequence of oversuppression of bone resorption. Usi

Trends in Incidence of Subtrochanteric F
โœ Zhong Wang; Timothy Bhattacharyya ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› American Society for Bone and Mineral Research ๐ŸŒ English โš– 124 KB

Increasing numbers of atypical hip fractures have been reported among patients with bisphosphonate use. However, the nature and extent of the problem are unknown despite recent investigations. To analyze national trends in hip fractures and medication use in the elderly US population, we respectivel